[google-translator]

currently enrolling clinical trials for IBC

(Designed for IBC patients or building on IBC research)

Home » Clinical Trials

Dual HER2 + chemo upfront IBC

Alternative Drug Names: Paclitaxel (Taxol brand in the US and abroad), Trastuzumab (Herceptin is the brand in the US and abroad), Pertuzumab (Perjeta brand in the US and abroad) Purpose of Trial: The purpose of this phase 2 study is to evaluate the effectiveness of...

Nintedanib IBC

Alternative Drug Names: Nintedanib was called BIBF 1120 (Ofev brand in the US) Purpose of Trial: The purpose of this phase 2 study is to evaluate the safety and efficacy of Nintedanib in the setting of metastatic IBC. Nintedanib is FDA approved outside of oncology,...

MK-3475 (Keytruda) IBC

Alternative Drug Names: MK-3475 is now Pembrolizumab (Keytruda brand in the US) Purpose of Trial: This is a phase 2 trial to determine the safety and efficacy of MK-3475 as a single drug in the setting of prior chemotherapy for metastatic IBC. MK-3475 has been FDA...

IBC And Brain Metastases

IBC And Brain Metastases

IBC metastasizes to the brain in about 19% of IBC patients within the first 2 years after diagnosis. Unfortunately the incidence of these metastases is increasing despite more effective systemic therapies that have controlled a subset of other organ metastases for...

Romidepsin & Abraxane IBC

Alternative Drug Names: Romidepsin (Istodax brand in the US). Romidepsin is also known as FK228, FR901228, or Depsipeptide; Abraxane is the branded name of Nab-Paclitaxel, a nanoparticle form of Paclitaxel Purpose of Trial: The phase 1 portion of this study is to find...

Translate »

Pin It on Pinterest

Share This
X
X